Kairos Pharma, Ltd. (KAPA)

AMEX·Healthcare·Biotechnology

$1.80

-0.55%

Mkt Cap $5.57M

No analyst coverage available

We don't have analyst ratings or price target data for Kairos Pharma, Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.